Cargando…

Pelvic recurrence after definitive surgery for locally advanced rectal cancer: a retrospective investigation of implications for precision radiotherapy field design

BACKGROUND: To analyze the local distribution of pelvic recurrence after total mesorectal excision, with a view to simplifying the formulation of optimal individualized radiotherapy plans. METHODS: We retrospectively investigated the data of 168 patients diagnosed with recurrent pelvic cancer treate...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chao, Zhu, Yinju, Tong, Tong, Xu, Ye, Guan, Yun, Wang, Jingwen, Wang, Huankun, Zhu, Ji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707074/
https://www.ncbi.nlm.nih.gov/pubmed/29221180
http://dx.doi.org/10.18632/oncotarget.21616
_version_ 1783282350869708800
author Li, Chao
Zhu, Yinju
Tong, Tong
Xu, Ye
Guan, Yun
Wang, Jingwen
Wang, Huankun
Zhu, Ji
author_facet Li, Chao
Zhu, Yinju
Tong, Tong
Xu, Ye
Guan, Yun
Wang, Jingwen
Wang, Huankun
Zhu, Ji
author_sort Li, Chao
collection PubMed
description BACKGROUND: To analyze the local distribution of pelvic recurrence after total mesorectal excision, with a view to simplifying the formulation of optimal individualized radiotherapy plans. METHODS: We retrospectively investigated the data of 168 patients diagnosed with recurrent pelvic cancer treated at Fudan University Shanghai Cancer Center between January 2008 and December 2012. The following were collected depending on availability: operative report, histological report, specimen photographs, initial preoperative images, images confirming local recurrence, and clinical history. RESULTS: A total of 203 lesions of local recurrence were identified. The most common sites of pelvic recurrence were the mesorectum, including the anastomotic stoma in 53.0% of cases; presacral space in 27.4%, and pelvic floor and perineum in 21.4% the cases. Recurrence was most common in the lower pelvic region (i.e., below the upper border of the acetabulum), accounting for approximately 76.2% (128 cases) of cases. In patients with mid-rectal and distal rectal carcinoma, CONCLUSIONS: Patients with pelvic cancer may benefit by individualized treatment plans aimed at achieving a balance between tumor control and minimal risk of irradiation-induced toxicity.
format Online
Article
Text
id pubmed-5707074
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-57070742017-12-07 Pelvic recurrence after definitive surgery for locally advanced rectal cancer: a retrospective investigation of implications for precision radiotherapy field design Li, Chao Zhu, Yinju Tong, Tong Xu, Ye Guan, Yun Wang, Jingwen Wang, Huankun Zhu, Ji Oncotarget Research Paper BACKGROUND: To analyze the local distribution of pelvic recurrence after total mesorectal excision, with a view to simplifying the formulation of optimal individualized radiotherapy plans. METHODS: We retrospectively investigated the data of 168 patients diagnosed with recurrent pelvic cancer treated at Fudan University Shanghai Cancer Center between January 2008 and December 2012. The following were collected depending on availability: operative report, histological report, specimen photographs, initial preoperative images, images confirming local recurrence, and clinical history. RESULTS: A total of 203 lesions of local recurrence were identified. The most common sites of pelvic recurrence were the mesorectum, including the anastomotic stoma in 53.0% of cases; presacral space in 27.4%, and pelvic floor and perineum in 21.4% the cases. Recurrence was most common in the lower pelvic region (i.e., below the upper border of the acetabulum), accounting for approximately 76.2% (128 cases) of cases. In patients with mid-rectal and distal rectal carcinoma, CONCLUSIONS: Patients with pelvic cancer may benefit by individualized treatment plans aimed at achieving a balance between tumor control and minimal risk of irradiation-induced toxicity. Impact Journals LLC 2017-10-07 /pmc/articles/PMC5707074/ /pubmed/29221180 http://dx.doi.org/10.18632/oncotarget.21616 Text en Copyright: © 2017 Li et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (http://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Li, Chao
Zhu, Yinju
Tong, Tong
Xu, Ye
Guan, Yun
Wang, Jingwen
Wang, Huankun
Zhu, Ji
Pelvic recurrence after definitive surgery for locally advanced rectal cancer: a retrospective investigation of implications for precision radiotherapy field design
title Pelvic recurrence after definitive surgery for locally advanced rectal cancer: a retrospective investigation of implications for precision radiotherapy field design
title_full Pelvic recurrence after definitive surgery for locally advanced rectal cancer: a retrospective investigation of implications for precision radiotherapy field design
title_fullStr Pelvic recurrence after definitive surgery for locally advanced rectal cancer: a retrospective investigation of implications for precision radiotherapy field design
title_full_unstemmed Pelvic recurrence after definitive surgery for locally advanced rectal cancer: a retrospective investigation of implications for precision radiotherapy field design
title_short Pelvic recurrence after definitive surgery for locally advanced rectal cancer: a retrospective investigation of implications for precision radiotherapy field design
title_sort pelvic recurrence after definitive surgery for locally advanced rectal cancer: a retrospective investigation of implications for precision radiotherapy field design
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707074/
https://www.ncbi.nlm.nih.gov/pubmed/29221180
http://dx.doi.org/10.18632/oncotarget.21616
work_keys_str_mv AT lichao pelvicrecurrenceafterdefinitivesurgeryforlocallyadvancedrectalcanceraretrospectiveinvestigationofimplicationsforprecisionradiotherapyfielddesign
AT zhuyinju pelvicrecurrenceafterdefinitivesurgeryforlocallyadvancedrectalcanceraretrospectiveinvestigationofimplicationsforprecisionradiotherapyfielddesign
AT tongtong pelvicrecurrenceafterdefinitivesurgeryforlocallyadvancedrectalcanceraretrospectiveinvestigationofimplicationsforprecisionradiotherapyfielddesign
AT xuye pelvicrecurrenceafterdefinitivesurgeryforlocallyadvancedrectalcanceraretrospectiveinvestigationofimplicationsforprecisionradiotherapyfielddesign
AT guanyun pelvicrecurrenceafterdefinitivesurgeryforlocallyadvancedrectalcanceraretrospectiveinvestigationofimplicationsforprecisionradiotherapyfielddesign
AT wangjingwen pelvicrecurrenceafterdefinitivesurgeryforlocallyadvancedrectalcanceraretrospectiveinvestigationofimplicationsforprecisionradiotherapyfielddesign
AT wanghuankun pelvicrecurrenceafterdefinitivesurgeryforlocallyadvancedrectalcanceraretrospectiveinvestigationofimplicationsforprecisionradiotherapyfielddesign
AT zhuji pelvicrecurrenceafterdefinitivesurgeryforlocallyadvancedrectalcanceraretrospectiveinvestigationofimplicationsforprecisionradiotherapyfielddesign